Sujata Rawat at the Adesh Hospital in Bathinda, India, points out that the study didn’t include people without cancer as a comparison, and there may be other conditions that change the profile of metabolites in similar ways. I would like to see this profile validated in a larger prospective data set, but this initial report shows much promise.” “Most currently available tests for early detection have difficulty identifying ovarian cancer while it is still at an early stage. “Effective non-surgical testing for early-stage ovarian cancer has been elusive for more than five decades,” he says. Become a specialist in Ovarian Cancer Epidemiology and Diagnosis with this Postgraduate Certificate.

The results are promising, but the test needs to be validated in a larger group of people, says Eric Eisenhauer at Massachusetts General Hospital in Boston. The new test accurately identified most of those with early-stage ovarian cancer and performed much better than the CA125 test in diagnosing ovarian cancer at an earlier stage. In resource-limited settings, the diagnosis of ovarian cancer can be challenging. Next, they tested the fluids from the remaining 123 women for these seven metabolites and carried out the CA125 test on them. Ovarian cancer is a spectrum of several histologically distinct tumor types that differ in etiology, response to therapy, and prognosis.

Download ovarian cancer diagnosis